Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
A pediatric trial evaluating Yttrium-90 radioembolization for liver tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: Cost-effectiveness of RFA vs. PEI for Early-stage HCC [NA]
A completed trial compares the cost-effectiveness of radiofrequency ablation versus percutaneous ethanol injection for early-stage hepatocel…
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 study evaluating transarterial chemoembolization combined with tyrosine kinase inhibitors and tislelizumab in unresectable hepatocel…
-
CLINICAL_TRIALS trial_result · 2024-06-05Clinical Trial Update: Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC) [Phase 2]
A Phase 2 trial evaluating atezolizumab and bevacizumab with Y-90 radioembolization for unresectable hepatocellular carcinoma was terminated…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma [NA]
Completed trial comparing transarterial chemoembolization versus proton beam radiotherapy for hepatocellular carcinoma; results have been po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: A Study of the Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 study evaluating the combination of AK105 (anti-PD-1) and Anlotinib for first-line hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC
A completed clinical trial comparing lenvatinib versus bevacizumab plus immune checkpoint inhibitors and HAIC in unresectable hepatocellular…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports results for the combination of sorafenib tosylate and pembrolizumab in advanced or metastatic hepa…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma [Phase 3]
Phase 3 clinical trial evaluating postoperative transarterial chemoembolization for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: cTACE Plus Sintilimab for Unresectable Intermediate-stage HCC With Beyond Up-to-seven Criteria [Phase 2]
Phase 2 study evaluating cTACE plus sintilimab for unresectable intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria has …
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery [Phase 1]
Phase 1 clinical trial update for ITGA6-targeted NIR-II fluorescence image-guided surgery in hepatocellular carcinoma, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: An Intraoperative Guidance Platform for Radio Frequency Ablation [NA]
A completed clinical trial evaluated an intraoperative guidance platform to assist radiofrequency ablation for hepatocellular carcinoma, wit…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Postoperative Symptoms in Chinese Liver Cancer Patients: Network Analysis
This clinical trial evaluated postoperative symptoms in hepatocellular carcinoma patients undergoing curative liver surgery using network an…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: The Safety and Efficacy Evaluation of XSLJZ in Advanced Hepatocellular Carcinoma Patients With Multiple Protein Kinase Inhibitor Therapy: A Randomized, Double-Blind, Controlled Trial [Phase 4]
A Phase 4 randomized, double-blind trial evaluated the safety and efficacy of XSLJZ in advanced hepatocellular carcinoma patients previously…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure [Phase 2]
Phase 2 clinical trial evaluating nimotuzumab in combination with immune checkpoint inhibitors for advanced hepatocellular carcinoma after f…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy [Phase 2]
Phase 2 clinical trial evaluating sequential transarterial chemoembolization (TACE) and stereotactic body radiation therapy (SBRT) followed …
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Natural Killer (NK) Cell Therapy in Locally Advanced HCC [Phase 2]
A Phase 2 clinical trial evaluating natural killer (NK) cell therapy for locally advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion [Phase 3]
This is a Phase 3 trial evaluating postoperative adjuvant sintilimab in hepatocellular carcinoma with microvascular invasion. The study stat…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Impact of Hepatectomy on HCC Recurrence
This clinical trial evaluating whether hepatectomy affects recurrence in hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Alone or in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating AK104 alone or in combination with lenvatinib for advanced Hepatocellular Carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
This is an update on a Phase 1/Phase 2 trial of AK104 plus lenvatinib in first-line advanced hepatocellular carcinoma. The study status is c…
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: Lenvatinib Combined With TACE and Camrelizumab in Conversion Resection for Advanced Hepatocellular Carcinoma (LEN-TAC Study) [Phase 3]
Phase 3 trial investigating lenvatinib combined with transarterial chemoembolization (TACE) and camrelizumab for conversion to resection in …
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy [NA]
Results from the HistoSonics histotripsy system trial for liver tumors have been posted. The study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: A Study to Evaluate SHR-1210 in Subjects With Advanced HCC [Phase 2]
Phase 2 trial of SHR-1210 in advanced hepatocellular carcinoma (non-resectable) completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model. [Phase 4]
A Phase 4 clinical trial evaluating efficacy and safety of neoadjuvant therapy in patients with resectable hepatocellular carcinoma (HCC) sc…